Medication info
Losartan Potassium and Hydrochlorothiazide Plus F Tablet

Losartan Potassium and Hydrochlorothiazide Plus F Tablet

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›100mg / 1 tabletHydrochlorothiazide›25mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
Light yellow oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 200700468 · Notified 2007.01.11 · Insurance code 642100320

Summary

Main use
Treatment of hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
○ Adults The usual dose of this medicine is 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg daily are not recommended. The maximum blood pressure-lowering effect generally occurs around 3 weeks after starting treatment. This medicine may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, start this medicine when the expected effect is not achieved with monotherapy. 1. Substitution therapy: This medicine may replace combination therapy with individually titrated losartan potassium and hydrochlorothiazide. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who have hypokalemia despite blood pressure control at this dose: Treatment may be started with 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg, which allows the hydrochlorothiazide dose to be reduced without reducing the overall blood pressure-lowering effect. Thereafter, continue to assess the clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. ○ Patients with renal impairment The usual dose may be administered when creatinine clearance is 30 mL/min or greater. Administration is not recommended in patients with more severe renal impairment, for whom loop diuretics are preferable to thiazide drugs. ○ Patients with hepatic impairment Administration is not recommended in these patients because the initial dose of losartan potassium of 25 mg required for patients with hepatic impairment who need dose adjustment cannot be administered with this medicine.
Child dose
○ Children (under 18 years) Because there is no experience with use in children and adolescents, the losartan-hydrochlorothiazide combination should not be administered to children or adolescents.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Treatment of hypertension not controlled with monotherapy

  • Hypertension
View approved original text

This medication is used for patients with hypertension who have difficulty controlling their blood pressure with monotherapy. It helps to effectively lower blood pressure, reducing the risk of cardiovascular disease.

How to take

Adult dose

○ Adults The usual dose of this medicine is 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg daily are not recommended. The maximum blood pressure-lowering effect generally occurs around 3 weeks after starting treatment. This medicine may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, start this medicine when the expected effect is not achieved with monotherapy. 1. Substitution therapy: This medicine may replace combination therapy with individually titrated losartan potassium and hydrochlorothiazide. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who have hypokalemia despite blood pressure control at this dose: Treatment may be started with 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg, which allows the hydrochlorothiazide dose to be reduced without reducing the overall blood pressure-lowering effect. Thereafter, continue to assess the clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. ○ Patients with renal impairment The usual dose may be administered when creatinine clearance is 30 mL/min or greater. Administration is not recommended in patients with more severe renal impairment, for whom loop diuretics are preferable to thiazide drugs. ○ Patients with hepatic impairment Administration is not recommended in these patients because the initial dose of losartan potassium of 25 mg required for patients with hepatic impairment who need dose adjustment cannot be administered with this medicine.

Child dose

○ Children (under 18 years) Because there is no experience with use in children and adolescents, the losartan-hydrochlorothiazide combination should not be administered to children or adolescents.

Precautions

This medication should not be used during pregnancy, particularly in the second and third trimesters, as it can cause serious harm to the fetus. It should be discontinued immediately upon confirmation of pregnancy, and patients should follow their physician's instructions to ensure the health of the fetus and newborn. This medication should not be administered to patients with certain conditions or known hypersensitivity. For instance, patients with severely impaired kidney function or significant liver dysfunction, as well as those allergic to specific medications, should not use it. Patients with severely low blood pressure or issues with renal blood vessels, as well as those with electrolyte imbalances, should use this medication with caution. Elderly patients or those with certain chronic illnesses also require careful consideration. While taking this medication, dizziness, drowsiness, and symptoms of low blood pressure may occur, so caution is advised when driving or operating machinery. This medication may affect potassium levels in the blood, so potassium supplements or medications containing potassium should not be taken without consulting a physician. The hydrochlorothiazide component can cause electrolyte imbalances; hence, regular blood tests should be conducted to monitor electrolyte status. Additionally, this medication may cause photosensitivity; precautions should be taken to avoid sun exposure and protect the skin. If sudden changes in vision or eye pain occur while taking this medication, immediate consultation with a healthcare provider is necessary, and it should be discontinued if severe side effects are suspected. In case of overdose, symptoms such as low blood pressure or irregular heartbeat may occur, so adhering to the prescribed dosage is critical, and any unusual symptoms should prompt an immediate visit to a medical institution. Pregnant or nursing individuals should consult a physician before taking this medication, and caution is necessary during breastfeeding as this medication may affect the baby. There is insufficient experience with this medication in children and adolescents, so it is recommended not to administer it to this age group. When taking other medications concurrently, interactions may occur, so it is essential to inform and consult with healthcare professionals regarding current medications.

Side effects

  • Abdominal pain
  • edema
  • palpitations
  • low back pain
  • dizziness
  • cough
  • sinusitis
  • upper respiratory infection
  • rash
  • angioedema
Show 124 more
  • skin exfoliation
  • hemolysis
  • chest pain
  • facial edema
  • fever
  • orthostatic hypotension
  • syncope
  • angina
  • arrhythmia
  • cerebrovascular accident
  • hypotension
  • myocardial infarction
  • secondary atrioventricular block
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • dyspepsia
  • flatulence
  • gastritis
  • vomiting
  • malaise
  • anemia
  • gout
  • arm pain
  • joint pain
  • arthritis
  • fibromyalgia
  • hip pain
  • joint swelling
  • knee pain
  • leg pain
  • muscle cramps
  • muscle weakness
  • musculoskeletal pain
  • myalgia
  • shoulder pain
  • muscle stiffness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • insomnia
  • reduced libido
  • memory impairment
  • migraine
  • neuroirritability
  • panic disorder
  • sensory abnormality
  • peripheral neuropathy
  • sleep disturbances
  • drowsiness
  • tremors
  • dyspnea
  • epistaxis
  • nasal congestion
  • pharyngeal discomfort
  • respiratory congestion
  • rhinitis
  • venous sinus disorder
  • chest discomfort
  • alopecia
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity
  • pruritus
  • diaphoresis
  • urticaria
  • blurred vision
  • ocular pain
  • burning sensation
  • conjunctivitis
  • diminished vision
  • taste disturbance
  • tinnitus
  • erectile dysfunction
  • nocturia
  • polyuria
  • urinary tract infection
  • weakness
  • pancreatitis
  • jaundice
  • sialadenitis
  • convulsions
  • gastrointestinal irritation
  • aplastic anemia
  • agranulocytosis
  • leukopenia
  • thrombocytopenia
  • purpura
  • necrotizing vasculitis
  • pneumonia
  • pulmonary edema
  • acute respiratory distress syndrome
  • hyperglycemia
  • diabetes
  • muscle twitching
  • restlessness
  • renal failure
  • renal impairment
  • interstitial nephritis
  • sicca syndrome
  • erythema multiforme
  • toxic epidermal necrolysis
  • transient blurred vision
  • yellow vision
  • acute myopia
  • acute angle-closure glaucoma
  • choroidal effusion
  • vasculitis
  • anaphylaxis
  • hepatitis
  • intestinal vascular edema
  • dry cough
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a dark place, with a temperature maintained between 1 to 30 degrees Celsius at room temperature. Proper storage will help maintain the effectiveness of the medication and ensure safe usage.

Appearance and packaging

Appearance

Light yellow oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.